BCAX Form 144: 9,200 shares proposed sale

BCAX notice of proposed sale: a holder filed a Form 144 reporting an intended sale of 9,200 shares of Common Stock on 05/21/2026 related to an exercise of stock options and settled in cash.

Rhea-AI Filing Summary

BCAX notice of proposed sale: a holder filed a Form 144 reporting an intended sale of 9,200 shares of Common Stock on 05/21/2026 related to an exercise of stock options and settled in cash. The filing also lists multiple prior dispositions in March–April 2026.

Insights

Securities Compliance Analyst

Form 144 documents planned resale after option exercise and shows recent dispositions.

The notice reports an intended sale of 9,200 shares on 05/21/2026, described as resulting from an exercise of stock options and to be effected in cash. The excerpt lists prior sales of Common Stock on 03/03/2026, 03/04/2026, 03/23/2026, and 04/21/2026 with exact share and dollar amounts.

These entries reflect routine resale mechanics under Section 16 resale notice practice; the filing does not state purchaser identity, proceeds recipient beyond "Issuer" in the exercise row, or any market‑timing restrictions. Subsequent filings would show final settlement details and any Rule 144 volume/holding compliance.

Key Figures

Planned sale: 9,200 shares Estimated value (row): $187,883.32 Past sale 03/03/2026: 13,555 shares +3 more

6 metrics

Planned sale 9,200 shares Intended sale on 05/21/2026 from exercise of stock options

Estimated value (row) $187,883.32 Value listed alongside the 9,200‑share 05/21/2026 row

Past sale 03/03/2026 13,555 shares Disposition on 03/03/2026 for $246,909.75

Past sale 03/04/2026 2,963 shares Disposition on 03/04/2026 for $54,061.71

Past sale 03/23/2026 9,200 shares Disposition on 03/23/2026 for $170,348.12

Past sale 04/21/2026 9,200 shares Disposition on 04/21/2026 for $211,613.80

Key Terms

Form 144, exercise of stock options, cash

3 terms

Form 144 regulatory

"Filer Information | 144: Filer Information"

Form 144 is a document that investors must file with the government when they plan to sell a large number of shares of a company's stock. It helps ensure transparency so everyone knows how many shares are being sold and when, which can impact the stock's price.

exercise of stock options financial

"Common | 05/21/2026 | Exercise of stock options"

cash financial

"05/21/2026 | Exercise of stock options | Issuer | | | 9200 | 05/21/2026 | Cash"

FAQ

AI-generated questions and answers. How Rhea-AI works. Not financial advice.

What does BCAX's Form 144 report about the planned sale?

The Form 144 reports an intended sale of 9,200 shares of Common Stock on 05/21/2026 tied to an exercise of stock options. The filing records the method as cash and lists recent prior dispositions in March–April 2026.

How many shares and dollar amounts were sold by the filer in recent months?

The filing lists past dispositions of 13,555 shares ($246,909.75) on 03/03/2026 and 2,963 shares ($54,061.71) on 03/04/2026. It also shows 9,200 shares on 03/23/2026 ($170,348.12) and on 04/21/2026 ($211,613.80).

Is the planned sale associated with an option exercise or open‑market sale?

The excerpt explicitly lists the 05/21/2026 row as an exercise of stock options with settlement in cash. Other dated entries are recorded as sales during the past three months without additional method details in the excerpt.

Who receives proceeds from the reported transactions in the filing?

The exercise row identifies Issuer in the related column, indicating the exercise generated cash proceeds tied to the issuer. The filing excerpt does not state purchaser identities or detailed proceeds allocation for each prior sale.

AI-generated analysis. How Rhea-AI works. Not financial advice.

See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google

Add on Google Not now

Accepted by SEC EDGAR 05/21/2026 - 04:02 PM Learn about SEC filing dates

Form 144 Filer Information	UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 Form 144 NOTICE OF PROPOSED SALE OF SECURITIES PURSUANT TO RULE 144 UNDER THE SECURITIES ACT OF 1933
FORM 144

144: Filer Information

Filer CIK	0002034668
Filer CCC	XXXXXXXX
Is this a LIVE or TEST Filing?	LIVE TEST
Submission Contact Information
Name
Phone
E-Mail Address

144: Issuer Information

Name of Issuer	Bicara Therapeutics Inc.
SEC File Number	001-42271
Address of Issuer	116 HUNTINGTON AVENUE SUITE 703 BOSTON MASSACHUSETTS 02116
Phone	617-468-4219
Name of Person for Whose Account the Securities are To Be Sold	Hyep Ivan
See the definition of "person" in paragraph (a) of Rule 144. Information is to be given not only as to the person for whose account the securities are to be sold but also as to all other persons included in that definition. In addition, information shall be given as to sales by all persons whose sales are required by paragraph (e) of Rule 144 to be aggregated with sales for the account of the person filing this notice.
Relationship to Issuer	Officer

144: Securities Information

Title of the Class of Securities To Be Sold	Name and Address of the Broker	Number of Shares or Other Units To Be Sold	Aggregate Market Value	Number of Shares or Other Units Outstanding	Approximate Date of Sale	Name the Securities Exchange
Common	UBS Financial Services, Inc. 11 Madison Ave 4th Floor New York NY 10010	9200	187883.32	65703866	05/21/2026	NASDAQ

Furnish the following information with respect to the acquisition of the securities to be sold and with respect to the payment of all or any part of the purchase price or other consideration therefor:

144: Securities To Be Sold

Title of the Class	Date you Acquired	Nature of Acquisition Transaction	Name of Person from Whom Acquired	Is this a Gift?	Date Donor Acquired	Amount of Securities Acquired	Date of Payment	Nature of Payment *
Common	05/21/2026	Exercise of stock options	Issuer			9200	05/21/2026	Cash

* If the securities were purchased and full payment therefor was not made in cash at the time of purchase, explain in the table or in a note thereto the nature of the consideration given. If the consideration consisted of any note or other obligation, or if payment was made in installments describe the arrangement and state when the note or other obligation was discharged in full or the last installment paid.

Furnish the following information as to all securities of the issuer sold during the past 3 months by the person for whose account the securities are to be sold.

144: Securities Sold During The Past 3 Months

Name and Address of Seller	Title of Securities Sold	Date of Sale	Amount of Securities Sold	Gross Proceeds
Ivan Hyep 116 HUNTINGTON AVENUE SUITE 703 Boston MA 02116	Common	03/03/2026	13555	246909.75
Ivan Hyep 116 HUNTINGTON AVENUE SUITE 703 Boston MA 02116	Common	03/04/2026	2963	54061.71
Ivan Hyep 116 HUNTINGTON AVENUE SUITE 703 Boston MA 02116	Common	03/23/2026	9200	170348.12
Ivan Hyep 116 HUNTINGTON AVENUE SUITE 703 Boston MA 02116	Common	04/21/2026	9200	211613.80

144: Remarks and Signature

Remarks
Date of Notice	05/21/2026
Date of Plan Adoption or Giving of Instruction, If Relying on Rule 10b5-1	02/13/2025
ATTENTION:
The person for whose account the securities to which this notice relates are to be sold hereby represents by signing this notice that he does not know any material adverse information in regard to the current and prospective operations of the Issuer of the securities to be sold which has not been publicly disclosed. If such person has adopted a written trading plan or given trading instructions to satisfy Rule 10b5-1 under the Exchange Act, by signing the form and indicating the date that the plan was adopted or the instruction given, that person makes such representation as of the plan adoption or instruction date.
Signature	/s/ UBS Financial Services Inc., as attorney-in-fact for Ivan Hyep
ATTENTION: Intentional misstatements or omission of facts constitute Federal Criminal Violations (See 18 U.S.C. 1001)